Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: David Lake who wrote (3904)	7/2/1998 2:38:00 PM
From: Rajiv	Read Replies (1) \| Respond to of 5736

From briefing.com 14:22 ET Chromatics Color Sciences (CCSI) 5 7/32 +29/32: Stock benefitting from "buy" rating issued by Janssen/Myers Associates. Firm also called comments by Asensio & Co baseless. Says company has received FDA approval for product and should be joining a partner soon to bring the product to market. On June 9, Asensio & Co, a professional short-selling outfit, said that CCSI grossly exaggerated the market for its TLc-BiliTes, a product that tests infants for jaundice. At the time, the firm issued a "strong sell" recommendation on the stock, knocking the issue down several points. For more information on this story, see the Press Releases from the past month.

To: David Lake who wrote (3904)	7/2/1998 3:24:00 PM
From: Gurupup	Read Replies (1) \| Respond to of 5736

David, Your question is the major question. We all know where the stock came down from, and assuming, which I do, that we will have a partner for world wide distribution, I would offer this scenario. Let's treat this with a grain of salt, but I firmly believe it. 1. We get a partner. People will see the split between the partners. 2. Each of us then has to construct a model based on what you think the penetration can be year1,2,3. 3. Next question is pricing, and because of confidential negotations, we don't have that, but assumptions will have to be made . 4. A partner IMO blesses the technology, therefore maybe somebody will believe other markets lie ahead, i.e, cosmetics, and dentistry. 5. I believe we do have a short position of some magnitude, and all margin calls have been met, and if you were not forced out at $4, you ain't leaving at $5 1/2. Now maybe the margin department becomes our friend, as leverage works both ways, I am told. 6. People that were looking at the stock at $14, assuming a deal, might like it a little better at $6-7. 7. Outside of the plunder, nothing has changed. 8. I said yesterday there was $ 1/2 point down and $4-5 up. That is the starting point, not the end. We are going back up.

To: David Lake who wrote (3904)	7/2/1998 4:18:00 PM
From: Matt Black	Read Replies (1) \| Respond to of 5736

I'm not one to put any faith in rumors normally, but in this case you might want to know what's been going around. My best guess from what I've heard is that the deal is coming next week. When the deal is announced, beware of the spin the shorts will try to put on it, because this will be the time for panic and they will say anything to try to squelch the ensuing blood bath when the stock returns to the mid-teens. This will be the biggest short squeeze in years in a stock this highly visible! The longs will have fresh reinforcements to keep the heat on too, because once the news is announced the onslaught of positive press releases, letters to brokers, advertisements, etc. from their PR firm (remember Hills and Knowlton) will begin. It will be amazing how everyone will forget Assensio's lies and innuendo once there is a deal and everyone can see the proof! I'm sure Barbara Payne in the A$$ will have some cutsie comeback to these comments, but don't bother to expect any answer from me. Matt (couldn't stay in lurk mode)